Prasad S. Adusumilli, MD, FACS

About Me

I am a thoracic surgeon with expertise in the diagnosis and treatment of cancers in the chest — lung cancer, esophageal cancer, mesothelioma, thymoma, mediastinal and chest wall tumors, and cancers metastatic to lung and pleura.

Read more

My clinical interests include systematic workup of lung nodules for early diagnosis of lung cancer, accurate staging of thoracic cancers by endoscopic methods such as endobronchial ultrasound (EBUS), and video-assisted thorascopic surgery (VATS). I take pride in effective communication with patients, family members, and their primary care physicians by constant and direct access. I perform minimally invasive, robotic, and open surgical procedures with a focus on patient-oriented outcomes (cancer control, quality of life).

I am involved in clinical research, and am currently the co-Principal Investigator on two trials at Memorial Sloan Kettering:  Protocol 11-037 and Protocol 11-192.

I conduct laboratory research focused on the development of biomarkers (blood tests) for early detection of cancer and gene therapy for thoracic cancers. These therapies include immunotherapy (enhancing patients’ own immune systems using genetic and cell engineering) and oncolytic viral therapy (killing cancer cells using genetically engineered viruses).

This research is supported by the National Cancer Institute, the Department of Defense, the American Association for Cancer Research, the International Association for the Study of Lung Cancer, the National Lung Cancer Partnership, the American Association for Thoracic Surgery, the Mesothelioma Applied Research Foundation, the Esophageal Cancer Education Foundation, the New York State Empire Clinical Research Investigator Program, the Stony Wold-Herbert Fund, and Memorial Sloan Kettering’s Experimental Therapeutics Center, as well as several other foundations.

I mentor surgical trainees, research fellows, and bioengineering students (from the City College of New York). The strength of their training is reflected in their multiple presentations at international conferences and peer-reviewed publications.

  • Clinical Expertise: Lung Cancer, Esophageal Cancer, Mediastinal and Chest Wall Tumors, Mesothelioma, Thymoma, Cancers Metastatic to Lung and Pleura, Carcinoid; Video-assisted Thoracic Surgery (VATS), Minimally-invasive and Robotic-assisted Surgery, Laparoscopy, Lobectomy, Bronchoscopy, Endobronchial Ultrasound (EBUS), Laser Surgery, Gastrointestinal Endoscopy, Tracheal and Esophageal Stents, PleurX catheter placement
  • Languages Spoken: English
  • Education: MD, Guntur Medical College (India)
  • Residencies: All India Institute of Medical Sciences (New Delhi, India); Southampton University Hospitals (UK); Maimonides Medical Center; Lenox Hill Hospital
  • Fellowships: Memorial Sloan Kettering Cancer Center; University of Pittsburgh
  • Board Certifications: Thoracic Surgery; General Surgery

My Research

View my lab

See Prasad S. Adusumilli’s laboratory
research at Memorial Sloan Kettering.

See My Colleagues


Selected Books and Book Chapters
“Non-surgical staging of esophageal carcinoma.” Adusumilli PS, Patel AN. In: The SAGES Manual of Strategic Decision Making: Case Studies in Minimal Access Surgery. Scott-Conner C, ed. New York: Springer; 2008.

Kaplan USMLE Step3 Qbook. 3rd ed. Levy E, Manley MS, Manley LD, Anschel DJ, Adusumilli PS. New York: Kaplan Medical; 2006.

Read more

Brain death and organ transplantation in India. 2nd ed. Peush S, Pande V, Prasad AS, Reddy KS, Nundy S, eds. New Delhi: Oxford UP; 1999.

Visit PubMed for a full listing of Prasad S. Adusumilli’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.